The pahtway p2057 has 35 genes in the original annotation. Currently, there are 20 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
| Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
| 8325 | FZD8 | FZ-8 | hFZ8 | frizzled class receptor 8 | | | 10p11.21 |
| 25805 | BAMBI | NMA | BMP and activin membrane-bound inhibitor | | | 10p12.3-p11.2 |
| 133 | ADM | AM | PAMP | adrenomedullin | | | 11p15.4 |
| 1910 | EDNRB | ABCDS | ET-B | ET-BR | ETB | ETB1 | ETBR | ETRB | HSCR | HSCR2 | WS4A | endothelin receptor type B | | | 13q22 |
| 2290 | FOXG1 | BF1 | BF2 | FHKL3 | FKH2 | FKHL1 | FKHL2 | FKHL3 | FKHL4 | FOXG1A | FOXG1B | FOXG1C | HBF-1 | HBF-2 | HBF-3 | HBF-G2 | HBF2 | HFK1 | HFK2 | HFK3 | KHL2 | QIN | forkhead box G1 | | | 14q13 |
| 8631 | SKAP1 | HEL-S-81p | SCAP1 | SKAP55 | src kinase associated phosphoprotein 1 | | | 17q21.32 |
| 63827 | BCAN | BEHAB | CSPG7 | brevican | | | 1q31 |
| 3075 | CFH | AHUS1 | AMBP1 | ARMD4 | ARMS1 | CFHL3 | FH | FHL1 | HF | HF1 | HF2 | HUS | complement factor H | | | 1q32 |
| 182 | JAG1 | AGS | AHD | AWS | CD339 | HJ1 | JAGL1 | jagged 1 | | | 20p12.1-p11.23 |
| 129446 | XIRP2 | CMYA3 | xin actin binding repeat containing 2 | | | 2q24.3 |
| 6092 | ROBO2 | SAX3 | roundabout guidance receptor 2 | | | 3p12.3 |
| 5099 | PCDH7 | BH-Pcdh | BHPCDH | PPP1R120 | protocadherin 7 | | | 4p15 |
| 6999 | TDO2 | TDO | TO | TPH2 | TRPO | tryptophan 2,3-dioxygenase | | | 4q32.1 |
| 57556 | SEMA6A | HT018 | SEMA | SEMA6A1 | SEMAQ | VIA | semaphorin 6A | | | 5q23.1 |
| 5480 | PPIC | CYPC | peptidylprolyl isomerase C | | | 5q23.2 |
| 3910 | LAMA4 | CMD1JJ | LAMA3 | LAMA4*-1 | laminin subunit alpha 4 | | | 6q21 |
| 4082 | MARCKS | 80K-L | MACS | PKCSL | PRKCSL | myristoylated alanine rich protein kinase C substrate | | | 6q22.2 |
| 26136 | TES | TESS | TESS-2 | testin LIM domain protein | | | 7q31.2 |
| 4232 | MEST | PEG1 | mesoderm specific transcript | | | 7q32 |
| 3620 | IDO1 | IDO | IDO-1 | INDO | indoleamine 2,3-dioxygenase 1 | | | 8p11.21 |